CA
NZ
UK
AU
IND
US
Encompass Health Corporation filed its quarterly report on Form 10-Q with the U.S. Securities and Exchange Commission on August 7, 2026, covering the fiscal quarter ended June 30, 2026.
News Corporation filed its Annual Report on Form 10-K with the U.S. Securities and Exchange Commission on August 7, 2026, covering the fiscal year ended June 30, 2026.
Applied Optoelectronics (NASDAQ:AAOI) shares are up 13.27% in pre-market trading, near $140.71, after closing Wednesday at $124.22, rebounding sharply after the stock initially slid in after-hours trading following Thursday's report. Applied Optoelectronics is a vertically integrated designer and manufacturer of fiber-optic networking products, serving …
Beacon Financial Corporation (NYSE: BBT) filed its quarterly report on Form 10-Q for the period ended June 30, 2026, with the U.S. Securities and Exchange Commission on August 7, 2026, disclosing consolidated financial results and balance sheet data for the three and six months …
First Community Bankshares, Inc. filed its Quarterly Report on Form 10-Q for the period ended June 30, 2026 with the Securities and Exchange Commission, disclosing condensed consolidated balance sheet figures and other financial data as of that date.
Verastem Oncology, Inc. (NASDAQ:VSTM) traded up approximately 7.95 percent in pre-market activity, near $6.38 versus Wednesday's close of $5.91. Second quarter net product revenue reached $40.1 million, up sharply from $2.1 million a year earlier, driven by early sales of AVMAPKI FAKZYNJA CO PACK, …
Ardelyx, Inc. (NASDAQ:ARDX) traded down approximately 17.04 percent in pre-market activity, near $4.04 versus Wednesday's close of $4.87, extending a decline that began immediately after the company's after-hours release. Revenue of $118 to $121 million fell short of the $121.6 million consensus, while the …
Halozyme Therapeutics, Inc. (NASDAQ:HALO) traded around $90.00 in pre-market activity, up approximately 4.94 percent from Wednesday's close of $85.76. Total revenue grew 48 percent year over year to $481 million, well ahead of the roughly $404 million consensus, while non-GAAP EPS of $2.28 beat …
Organogenesis Holdings Inc. (NASDAQ:ORGO) traded down approximately 20.12 percent in pre-market activity, near $1.93 versus Wednesday's close of $2.41. Second quarter net product revenue fell 58 percent year over year to $42.8 million, with advanced wound care sales declining 61 percent, even as total …
QuidelOrtho Corporation (NASDAQ:QDEL) traded down approximately 20.34 percent in pre-market activity, near $13.00 versus Wednesday's close of $16.32. Second quarter revenue grew 2 percent to $630.9 million, or nearly 6 percent excluding China, and adjusted EPS of $0.13 beat the $0.04 loss estimate, but …
Please wait processing your request...